Gerstein, H. C. et al. (2022) Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: the ELIXA trial. Diabetes, Obesity and Metabolism, 25(4), pp. 1125-1129. (doi: 10.1111/dom.14954) (PMID:36546588)
Full text not currently available from Enlighten.
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Additional Information: | The ELIXA trial was funded by Sanofi. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McMurray, Professor John and Kober, Professor Lars |
| Authors: | Gerstein, H. C., Wolsk, E., Claggett, B., Diaz, R., Dickstein, K., Hess, S., Køber, L., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Tardif, J.-C., and Pfeffer, M. A. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Diabetes, Obesity and Metabolism |
| Publisher: | Wiley |
| ISSN: | 1462-8902 |
| ISSN (Online): | 1463-1326 |
| Published Online: | 22 December 2022 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details